Drug recall
Lupron Depot Injection, (leuprolide acetate for depot suspension), 4 Month 30 mg, Single Dose Administratioin…
FDA recall event 30812 · Class II · Tap Pharmaceutical Prod
Key facts
| Event ID | 30812 |
|---|---|
| Recall numbers | D-117-5, D-118-5 |
| Recalling firm | Tap Pharmaceutical Prod |
| Product type | Drugs |
| Products | Lupron Depot Injection, (leuprolide acetate for depot suspension), 4 Month 30 mg, Single Dose Administratioin Kit with prefilled dual-chamber syringe, IM injection, Rx only, Kit includes: One…, Lupron Depot Injection (leuprolide acetate for depot suspension) 7.5mg, Single Dose Administration Kit with prefilled dual-chamber syringe, IM injection, Rx Only, Kit includes: One prefilled dual… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Subpotent; clumping of the powdered medication in the diluent may interfere with delivery of the full therapeutic dose, Subpotent; clumping of the powdered medication in the diluent may interfere with delivery of the full therapeutic dose. |
| Initiation date | Jan 10, 2005 |
| City | Lake Forest |
| Country | United States |
| FEI number | 3004447666 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports